Rossella De Marco
Udine, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Integrin-Specific Stimuli-Responsive Nanomaterials for Cancer Theranostics.
Journal: Pharmaceutics
Published: September 30, 2024
Peptide direct growth on poly(acrylic acid)/poly(vinyl alcohol) electrospun fibers coated with branched poly(ethylenimine): A solid-phase approach for scaffolds biofunctionalization.
Journal: Colloids and surfaces. B, Biointerfaces
Published: March 18, 2024
Dual-targeting peptides@PMO, a mimetic to the pro-apoptotic protein Smac/DIABLO for selective activation of apoptosis in cancer cells.
Journal: Frontiers in pharmacology
Published: June 09, 2023
APE1 interacts with the nuclear exosome complex protein MTR4 and is involved in cisplatin- and 5-fluorouracil-induced RNA damage response.
Journal: The FEBS journal
Published: May 12, 2022
Integrin-Targeting Dye-Doped PEG-Shell/Silica-Core Nanoparticles Mimicking the Proapoptotic Smac/DIABLO Protein.
Journal: Nanomaterials (Basel, Switzerland)
Published: May 22, 2020
Functional Selectivity and Antinociceptive Effects of a Novel KOPr Agonist.
Journal: Frontiers in pharmacology
Published: October 17, 2019
Constraining Endomorphin-1 by β,α-Hybrid Dipeptide/Heterocycle Scaffolds: Identification of a Novel κ-Opioid Receptor Selective Partial Agonist.
Journal: Journal of medicinal chemistry
Published: June 15, 2018
DS-70, a novel and potent α4 integrin antagonist, is an effective treatment for experimental allergic conjunctivitis in guinea pigs.
Journal: British journal of pharmacology
Published: December 19, 2017
Tryptophan-Containing Non-Cationizable Opioid Peptides - a new chemotype with unusual structure and in vivo activity.
Journal: Future medicinal chemistry
Published: November 14, 2017
Last Updated: 09/26/2026